Chemoinformaics analysis of 5-Azuleneacetic Acid
| Molecular Weight | 252.398 | nRot | 2 |
| Heavy Atom Molecular Weight | 224.174 | nRig | 12 |
| Exact Molecular Weight | 252.209 | nRing | 2 |
| Solubility: LogS | -5.631 | nHRing | 0 |
| Solubility: LogP | 4.556 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 46 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 46.9942 |
| nHD | 0 | BPOL | 30.6938 |
| QED | 0.697 |
| Synth | 4.076 |
| Natural Product Likeliness | 1.239 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.272 |
| Pgp-sub | 0 |
| HIA | 0.005 |
| CACO-2 | -4.654 |
| MDCK | 0.0000556 |
| BBB | 0.837 |
| PPB | 0.873168 |
| VDSS | 1.229 |
| FU | 0.0583471 |
| CYP1A2-inh | 0.742 |
| CYP1A2-sub | 0.839 |
| CYP2c19-inh | 0.222 |
| CYP2c19-sub | 0.945 |
| CYP2c9-inh | 0.671 |
| CYP2c9-sub | 0.23 |
| CYP2d6-inh | 0.018 |
| CYP2d6-sub | 0.606 |
| CYP3a4-inh | 0.778 |
| CYP3a4-sub | 0.641 |
| CL | 12.38 |
| T12 | 0.105 |
| hERG | 0.038 |
| Ames | 0.059 |
| ROA | 0.031 |
| SkinSen | 0.661 |
| Carcinogencity | 0.059 |
| EI | 0.1 |
| Respiratory | 0.782 |
| NR-Aromatase | 0.002 |
| Antiviral | Yes |
| Prediction | 0.774657 |